Skip to main content

Published locations for Study finds no benefit from lapatinib for HER2-positive gastric cancer patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Study finds no benefit from lapatinib for HER2-positive gastric cancer patients

User login

  • Reset your password
  • /content/study-finds-no-benefit-lapatinib-her2-positive-gastric-cancer-patients
  • /oncologypractice/article/104878/gastroenterology/study-finds-no-benefit-lapatinib-her2-positive
  • /hematology-oncology/article/104878/gastroenterology/study-finds-no-benefit-lapatinib-her2-positive